Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks hopefully it can get sticked by someone....all of the info is there...big thing I saw was the huge growth report with Bueno Cell listed..
This will absolutely keep ripping no downside no convertible debt, low float, the company they just signed run by Francisco Bunt is IBO Cell, which does business as Bueno Cell. They went from $0 Rev to $60M rev in 4 years. And a independent report cites them as having 60% compound growth now through 2024 which would place them at in the $300m per year range. Plus they are hinting at all of this laying the groundwork for 5g and pinging telefonica and tmobile:
We are working on our 2Q M&A plan soon to be announced #5G #NASDAQ #TELEFONICA https://t.co/YyagEbK0a9 pic.twitter.com/Kuyz2Cojpl
— iQSTEL Inc. (OTCQX: IQST) (@IQstel) March 24, 2020
for sure, the newly company IBO Cell does business as Bueno Cell in Mexico, who according to a report 6 months ago is supposed to drive growth in Mexico for small operators, in the machine to machine segment like the internet of things and machine connections....60% compound annual growth....so 30M rev turns to 50M next year and 90M after that...from this one new company to IQST
https://www.verdict.co.uk/mexico-mobile-subscriptions/
the aquired is IBO Cell which is called Bueno Cell, 60% CAGR report!
https://www.bnamericas.com/en/news/america-movil-signs-six-new-mvnos-in-mexico
https://www.verdict.co.uk/mexico-mobile-subscriptions/
the aquired is IBO Cell which is called Bueno Cell, 60% CAGR report!
https://www.bnamericas.com/en/news/america-movil-signs-six-new-mvnos-in-mexico
https://www.verdict.co.uk/mexico-mobile-subscriptions/
They finally will get the attention of the big boys now who want to add $50M rev to their coffers....this IBO CELL they just acquired does $60M rev annually from $0 rev in just 4 years, IQST is now 51% owner or $29M rev.
IQST is rocketing toward $100M annual rev, profit margins usually in the 10% area.
Here is the aquired companies registration
http://www.ift.org.mx/sites/default/files/15903-d.pdf
110 calls should do well next week
Lower medicare age good idea
https://www.cnbc.com/2020/04/09/biden-proposes-plans-on-medicare-and-student-debt-as-job-losses-soar.html
bought lots of 100 calls...on fire...sanders is out into the 200's coming...that report fails to address all of the 0 cost sign ups that occur with referrals and online searchers.....overall churn has not increased, may even decrease as the medicare advantage plans are getting so strong due to government push that people keeping them for longer and longer
I called this a ways back, Sanders is out of the race as of yesterday is why the short report to try and cover....these numbers are conservative, medicare advantage plans, by far their biggest seller, is seeing commission rate increases of 5% compound annually, the lifetime value of 1000 today will be 1250 per sign up within 3 years...the EBIDTA margin here in the 25% area will be 35% shortly...agents across the country use the EHTH portal to help find their clients the best drug plan, when the best drug plan is not one they rep, they hand the sale off to EHTH, many thousands of free sales to EHTH quarterly.....
2019 500m rev 140m gross
2020 650m rev 200m gross
2021 850m rev 275m gross
2022 1.1b rev 400m gross
2025 2b rev 700m gross
There are typos in the short report and on a cash basis for 2020 the have operating profit if 50m lol....the report is off......each week more sales are done at near 0 cost as they get referrals. MA plans are getting stronger and people stay with their plans longer...not for shorter timeframes.....bet ehth gets the reporters in trouble legally or at least financially
Crazy, he will have to be investigated. EHTH puts constraints on lifetime value of sales for precisely the unknown...if/when the actual money collected is greater its a "tail" and they add it to revenue and profit. On a cash basis they are collecting around $250m in 2020 with all in costs around $200M...so even on a cash basis they are profiting $50M EBITDA in 2020 lol plus the extra as plan stay on the books 2021 and 2022 etc....
Medicare Advantage, their biggest seller, has commission rates that have moved up each of the last 5 years and will do so for the next 5. The profit margin on these sales is expanding.....
EHTH gets no cost referrals every day from people who had friends who signed up already...easily doing $200M EBIDTA here by 2021....
a big squeeze just starting it appears I saw lotta air shares from 15 to 25
Would rather make 5 to 10x my investment moving up then at best 50% move down every time
6 week treatments....120k annual course....so 15k or so rev and profit per treated person.
Wow last time saw something like this the pps went 3x higher than the offer price
probably a few Trillion in sales between testing, immunization, and treatment up for grabs....cytokines evidently works in those who are hospitalized....this is a seasonal disease as is obvious unfortunately going to to flare every year, 1.5B is nada
I think its so thin looking at a few hundred percent increase today, obviously 10s of billions in potential
you are correct I was wrong sorry about that...lurking here for entry....home market is where the $ is at.....they need approval to go oup
Home kits banned....boost to those who do in office
https://www.google.com/amp/s/techcrunch.com/2020/03/23/updated-fda-covid-19-testing-guidelines-specifically-disallows-at-home-sample-colllection/amp/
Seasonal unfortunately too.
You want to be with who can produce the most tests....that's why aytu is with who they are with....fulfill 100,000 weekly billion dollar company in china is the partner
Anyone know what a kit sells for $
100,000 kits weekly is the contract aytu has for north american delivery.....so 2m in 20 weeks
Several players. These guys cant fulfill American orders. Story shows the demand 500k sold so far overseas....aytu goal is to fulfill American orders not overseas. Probably 100m tests needed in total worldwide.....lots of kits sold by lots of companies...
See the test here. Used in China to keep the virus at bay in many parts of china by doing lots of testing....100,000 weekly coming to aytu. I said weekly...100m mc lol
https://www.healgen.com/blog-1
The test details here and at healgen website
https://m.facebook.com/healgenScientifcUSA/
here is the president last night referring to aytu make no mistake its aytu
This is the test mentioned here... https://mobile.twitter.com/rontherepublic1/status/1242233242541056001?s=21
All should read the top sticky 100,000 per week if needed.....was the test used in china
This is definitely what the president was referring to last night wowsa!
20m usa health workers to test seasonally for covid as well future years.....perpetual revenue for this disease....is this the gold standard blood prick rapid test....possibly......positives will undergo a second test swab.....probably upward of 100 million tests annually between usa canada and mexico
Data must be there with this one all will have slightly different tech and outcomes....
about to get really noticed government is seeking finger prick tests...they approved this test and are probably just awaiting results as use increases to make it the field standard for mass scale testing....someone is going to get that tagline
these kits ought to be stocked on shelves everywhere like tylenol
This may be the big winner, 10s of millions of kits sold seasonally like 3x to 5x the market cap in sales or 15x the valuation
Their kits will be stocked in homes like tylenol this is a forever virus that will mimic seasonal flu it seems.....hopefully less cases than flu seasonally...a lot less
Just massive they were going to roll out in hospitals first but now they can do consumer direct with no emergency waiver.....
Supplies running out already no greater demand then that for decn
https://www.cnn.com/2020/03/18/us/coronovirus-testing-supply-shortages-invs/index.html
Fda cleared way for decn last night and for others too
FDA Policy Change to Allow Rapid Domestic Expansion of Co-Diagnostics COVID-19 Test
Source: Business Wire
Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that a new FDA policy released last night aimed at expediting the availability of COVID-19 diagnostics will allow the Company to aggressively expand its presence in the U.S. market.
Co-Diagnostics was the first U.S. company to obtain a CE marking for a COVID-19 test, and international shipments have continued to escalate. In the past month, the Company has shipped its CE marked and research use Logix Smart™ COVID-19 test kits to countries all over the world. These include Italy, Germany, the United Kingdom, Turkey, Greece, the Philippines, Thailand, Australia, Paraguay, Ecuador, Israel, South Africa, and Canada, in addition to numerous shipments to customers and research institutions in the United States.
Previous domestic shipments to date have been in accordance with the FDA’s policy change on February 29, 2020 that allows U.S. CLIA laboratories to use the Company’s COVID-19, under certain conditions. Now, as a result of the change announced last night by the FDA, the Company’s test kit will soon be available for use by and marketed to a wide array of U.S. laboratories, without first requiring Emergency Use Authorization.
Co-Diagnostics CEO Dwight Egan remarked, “The ramifications of this new FDA policy are significant for our Company. This change will quickly afford Co-Diagnostics even more opportunities to serve the needs of laboratories nationwide, as we play an even larger role in responding to this pandemic. We applaud the FDA’s decision to recognize the dire need for increased access to high-quality COVID-19 tests, and to adapt as the situation demands in light of a public health emergency.
“With no known treatment or approved vaccine for the highly-infectious COVID-19, the need for accurate and rapid diagnoses has never been greater. Our cost-effective Logix Smart CODIV-19 test has been designed to run on a variety of commercially available platforms, with easy-to-interpret results in under two hours. We are confident in our ability to meet the growing demand for this diagnostic.”